126 related articles for article (PubMed ID: 11120970)
1. Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals.
Milewski S; Mignini F; Prasad R; Borowski E
Antimicrob Agents Chemother; 2001 Jan; 45(1):223-8. PubMed ID: 11120970
[TBL] [Abstract][Full Text] [Related]
2. Facilitated diffusion of glucosamine-6-phosphate synthase inhibitors enhances their antifungal activity.
Janiak A; Cybulska B; Szlinder-Richert J; Borowski E; Milewski S
Acta Biochim Pol; 2002; 49(1):77-86. PubMed ID: 12136959
[TBL] [Abstract][Full Text] [Related]
3. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase.
Milewski S; Chmara H; Andruszkiewicz R; Borowski E; Zaremba M; Borowski J
Drugs Exp Clin Res; 1988; 14(7):461-5. PubMed ID: 3149235
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design.
Wojciechowski M; Milewski S; Mazerski J; Borowski E
Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and biological activity of lipophilic derivatives of bicine conjugated with N³-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP)-an inhibitor of glucosamine-6-phosphate synthase.
Koszel D; Lącka I; Kozłowska-Tylingo K; Andruszkiewicz R
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):167-73. PubMed ID: 21635214
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase.
Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R
Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131
[TBL] [Abstract][Full Text] [Related]
7. A diffusible analogue of N(3)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid with antifungal activity.
Zgódka D; Milewski S; Borowski E
Microbiology (Reading); 2001 Jul; 147(Pt 7):1955-1959. PubMed ID: 11429472
[TBL] [Abstract][Full Text] [Related]
8. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides.
Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E
J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and anti-Candida albicans properties of L-4-oxalysine-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic-containing peptide analogues].
Feng S; Xu X; Zhang H
Yao Xue Xue Bao; 1998 Jun; 33(6):429-35. PubMed ID: 12016912
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP.
Milewski S; Mignini F; Covelli I; Borowski E
J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618
[TBL] [Abstract][Full Text] [Related]
11. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
12. Rational design of N-alkyl derivatives of 2-amino-2-deoxy-d-glucitol-6P as antifungal agents.
Melcer A; Łacka I; Gabriel I; Wojciechowski M; Liberek B; Wiśniewski A; Milewski S
Bioorg Med Chem Lett; 2007 Dec; 17(23):6602-6. PubMed ID: 17920268
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of novel ester derivatives of N(3)-(4-metoxyfumaroyl)-(S)-2,3-diaminopropanoic acid containing amide and keto function as inhibitors of glucosamine-6-phosphate synthase.
Pawlak D; Schielmann M; Wojciechowski M; Andruszkiewicz R
Bioorg Med Chem Lett; 2016 Aug; 26(15):3586-9. PubMed ID: 27324977
[TBL] [Abstract][Full Text] [Related]
14. Amide and ester derivatives of N3-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic acid: the selective inhibitor of glucosamine-6-phosphate synthase.
Zgódka D; Jedrzejczak R; Milewski S; Borowski E
Bioorg Med Chem; 2001 Apr; 9(4):931-8. PubMed ID: 11354676
[TBL] [Abstract][Full Text] [Related]
15. The influence of serum proteins on biological activity of anticandidal peptides containing N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid.
Kasprzak L; Milewski S; Gumieniak J; Borowski E
J Chemother; 1992 Apr; 4(2):88-94. PubMed ID: 1629751
[TBL] [Abstract][Full Text] [Related]
16. The influence of L-norvalyl-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic acid, an antifungal agent, on mammalian cells in tissue culture.
Bontemps-Gracz M; Milewski S; Borowski E
Acta Biochim Pol; 1991; 38(2):229-39. PubMed ID: 1814130
[TBL] [Abstract][Full Text] [Related]
17. Antihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP.
Milewski S; Mignini F; Micossi L; Borowski E
Med Mycol; 1998 Jun; 36(3):177-80. PubMed ID: 9776831
[TBL] [Abstract][Full Text] [Related]
18. Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.
Wakiec R; Gabriel I; Prasad R; Becker JM; Payne JW; Milewski S
Antimicrob Agents Chemother; 2008 Nov; 52(11):4057-63. PubMed ID: 18794383
[TBL] [Abstract][Full Text] [Related]
19. N3-oxoacyl derivatives of L-2,3-diaminopropanoic acid and their peptides; novel inhibitors of glucosamine-6-phosphate synthase.
Andruszkiewicz R; Jedrzejczak R; Zieniawa T; Wojciechowski M; Borowski E
J Enzyme Inhib; 2000; 15(5):429-41. PubMed ID: 11030083
[TBL] [Abstract][Full Text] [Related]
20. Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.
Gao PH; Cao YB; Jia XM; Cao YY; Quan H; Wang Y; Jiang YY
Int J Antimicrob Agents; 2006 Jul; 28(1):69-74. PubMed ID: 16782311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
